TCR2 Therapeutics Inc. buy Global_Player
Start price
18.09.22
/
50%
€2.22
Target price
18.09.23
-
Performance (%)
-14.79%
End price
01.10.22
€1.89
Summary
This prediction ended on 01.10.22 with a price of €1.89. The price of TCR2 Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.79%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% | 49.144% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% | 82.047% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% | 60.623% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% | 59.657% |
Comments by Global_Player for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy TCR2 Therapeutics Inc.